Medical charity to gain billions

Brown, P.
March 1992
New Scientist;3/7/92, Vol. 133 Issue 1811, p12
Reports that the Wellcome Trust, Britain's biggest medical charity, has announced its intention to sell a large part of its stake in the pharmaceuticals company Wellcome. Trust's investment in the company is 7.1 billion pounds; Expected amount the trust will spend this year; Where increases will be made.


Related Articles

  • Wellcome news.  // New Scientist;07/26/97, Vol. 155 Issue 2092, p55 

    Announces the availability of the medical research charity Wellcome Trust's 1997 CD-ROM.

  • Wellcome diversifies. Aldhous, P. // Nature;3/5/1992, Vol. 356 Issue 6364, p8 

    Informs that the Wellcome Trust, Britain's largest charitable research foundation, has decided to sell a large proportion of its 73.6 percent holding in the drugs company Wellcome plc. Expected short-term boost to the Trust's spending on medicalresearch; How much the Trust will spend on medical...

  • Wellcome Trust to list jobs, grants on line. Mundell, Ian // Nature;9/10/1992, Vol. 359 Issue 6391, p97 

    Looks at a new service to be created by the Wellcome Trust that will make job vacancies and funding sources in the biomedical sciences available electronically. The trust's Centre for Medical Science in London; The JANET electronic mail system; Charges; Laurence Smaje, the centers director; The...

  • Welcoming Wellcome.  // Nature;8/6/1992, Vol. 358 Issue 6386, p440 

    Opinion. Discusses the distinguished reputation of Britain's Medical Research Council (MRC) and looks at recent moves by the Wellcome Trust which may establish a second research council on the same scale.

  • Medical trust adopts the `honeypot' principle. Coghlan, Andy // New Scientist;2/13/93, Vol. 137 Issue 1860, p7 

    Reports on plans by the Wellcome Trust in Britain to build two new `centers of excellence.' Description of the plans; Costs; The centers' main program.

  • A Wellcome injection of cash. Brown, Phyllida // New Scientist;8/1/92, Vol. 135 Issue 1832, p12 

    Reports on the money the Wellcome Trust has received from the sale of part of its pharmaceutical company, which manufactures the AIDS drug zidovudine, and what it will do with this money. Key principle of the trust's policy; The trust will consult various organizations over the next year on how...

  • Wellcome sets sequencing project in motion. Dickson, David // Nature;11/9/1995, Vol. 378 Issue 6553, p120 

    Reports that Great Britain's Wellcome Trust has become the first funding agency on either side of the Atlantic to commit firm support for a plan to produce a full-length `low-pass' sequence of the complete human genome by the year 2002. Financial support to the Sanger Centre in England.

  • Wellcome news.  // New Scientist;3/7/92, Vol. 133 Issue 1811, p7 

    Reveals that Britain's Wellcome Trust intends to make more money available for research by selling about half of its take in the pharmaceuticals company Wellcome plc. Expected amount of money it will raise to go to research; Broad implications for medical research; Benefits of the extra money...

  • Wellcome Trust to launch transfer company. Dickson, David // Nature;3/2/1995, Vol. 374 Issue 6517, p6 

    Reports that the Wellcome Trust is planning to set up a technology-transfer company to help the scientists it funds to find commercial outlets for the results of their research. Anticipated guidelines from the Charity Commissioners emphasizing that charities have a duty to ensure that research...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics